WebMay 17, 2024 · The POINT trial builds on the previous Chinese CHANCE trial, which also showed a reduced ischemic event rate without an increased bleeding risk with 21 days of … WebSep 29, 2024 · Patient randomization has started in the pivotal phase 3 SPLASH trial exploring the novel PSMA-targeted therapy PNT2002 in patients with metastatic castration-resistant prostate cancer (mCRPC), according to POINT Biopharma, the developer of PNT2002. 1. The randomization phase was launched after successful completion of the …
Randomization starts in pivotal phase 3 mCRPC trial of novel …
WebDec 1, 2024 · A Phase 3, Open-Label, Randomized Study Evaluating Metastatic Castrate Resistant Prostate Cancer Treatment Using PSMA [Lu-177]-PNT2002 Therapy After … WebApr 12, 2024 · The largest space rocket ever built could splash down around the Hawaiian Islands within the next two weeks. SpaceX CEO Elon Musk tweeted Monday that his company's massive Starship rocket will ... list of kings of wessex
POINT Biopharma Provides Updated Efficacy and Safety Data from the …
Web18 hours ago · Vallow, 49, is currently on trial for murder in Boise, Idaho, after being accused of killing her two children, 16-year-old Tylee and seven-year-old adopted son JJ, in September 2024. WebApr 26, 2024 · The SPLASH trial is investigating the use of 177 Lu-PNT2002, a PSMA-targeted radioligand, in pre-chemotherapy metastatic castration-resistant prostate cancer … WebMar 27, 2024 · POINT Biopharma Signed Strategic Collaboration Agreement with Lantheus Holdings Inc. for POINT's PNT2002 and PNT2003 product candidates Completed enrollment for randomization phase of PNT2002's... imc iotf